New York Life Investment Management LLC Biogen Inc. Transaction History
New York Life Investment Management LLC
- $9.34 Billion
- Q2 2024
A detailed history of New York Life Investment Management LLC transactions in Biogen Inc. stock. As of the latest transaction made, New York Life Investment Management LLC holds 22,967 shares of BIIB stock, worth $3.99 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
22,967
Previous 22,628
1.5%
Holding current value
$3.99 Million
Previous $4.88 Million
9.12%
% of portfolio
0.06%
Previous 0.05%
Shares
9 transactions
Others Institutions Holding BIIB
# of Institutions
1,018Shares Held
128MCall Options Held
1.22MPut Options Held
1.4M-
Vanguard Group Inc Valley Forge, PA16.6MShares$2.88 Billion0.08% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$2.84 Billion2.78% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.53 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.1MShares$1.23 Billion0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.68MShares$987 Million0.83% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $25B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...